Ontology highlight
ABSTRACT: Hepatic steatosis is the initial manifestation of abnormal liver functions and often leads to liver diseases such as non-alcoholic fatty liver disease in humans and fatty liver syndrome in animals. In this study, we conducted a comprehensive analysis of a large chicken population consisting of 705 adult hens by combining host genome resequencing, liver transcriptome, proteome and metabolome analysis, as well as microbial 16S rRNA gene sequencing of each gut segment. The results showed the heritability (h2 = 0.25) and duodenal microbiability (m2 = 0.26) of hepatic steatosis were relatively high, indicating a large effect of host genetics and duodenal microbiota on chicken hepatic steatosis. Individuals with hepatic steatosis had low microbiota diversity and a decreased genetic potential to process triglyceride output from hepatocytes, fatty acid β-oxidation activity and resistance to fatty acid peroxidation. Furthermore, we revealed a molecular network linking host genomic variants (GGA6: 5.59-5.69 Mb), hepatic gene/protein expression (PEMT, phosphatidyl-ethanolamine N-methyltransferase), metabolite abundances (folate, S-adenosylmethionine, homocysteine, phosphatidyl-ethanolamine and phosphatidylcholine) and duodenal microbes (genus Lactobacillus) to hepatic steatosis, which could provide new insights into the regulatory mechanism of fatty liver development.
INSTRUMENT(S): Liquid Chromatography MS - alternating - hilic, Liquid Chromatography MS - alternating - reverse phase
SUBMITTER: Fangren Lan
PROVIDER: MTBLS7808 | MetaboLights | 2023-07-24
REPOSITORIES: MetaboLights
Action | DRS | |||
---|---|---|---|---|
MTBLS7808 | Other | |||
FILES | Other | |||
a_MTBLS7808_LC-MS_alternating_hilic_metabolite_profiling.txt | Txt | |||
a_MTBLS7808_LC-MS_alternating_reverse-phase_metabolite_profiling.txt | Txt | |||
files-all.json | Other |
Items per page: 5 1 - 5 of 9 |